ISRCTN34381594
Completed
Not Applicable
Delivering enhanced cardiovascular disease and hypertension care through private health facilities in Pakistan: a cluster randomized trial
niversity of Leeds (UK)0 sites912 target enrollmentJuly 26, 2012
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Hypertension / Cardiovascular Disease
- Sponsor
- niversity of Leeds (UK)
- Enrollment
- 912
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. All newly diagnosed hypertensive (systolic blood pressure \>140 mm Hg, diastolic blood pressure \>90 mm Hg)
- •2\. Male and female patients aged 25 years or more from the catchment population of the respective facility
Exclusion Criteria
- •1\. Pregnant women
- •2\. Persons with advanced chronic disease
- •3\. Person with conditions that cause secondary hypertension
- •4\. Person with known history of hypertension and/or CVD treatment in the past
- •5\. Person not likely to stay in the area for the required follow\-up period of 15 months
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Cardiovascular Diseases – Enhancing Healthcare through cross-Sectoral Routine data integration: Use Case EmergencyG45I60I61I63Transient cerebral ischaemic attacks and related syndromesSubarachnoid haemorrhageIntracerebral haemorrhageCerebral infarctionDRKS00029103niversitätsklinikum Würzburg1,080
Completed
Not Applicable
Prevention of cardiovascular disease by improvement of life-style with oral health approachCardiovascular disease, Periodontal diseaseJPRN-UMIN000039693Kanagawa Dental University200
Not yet recruiting
Not Applicable
Cardiovascular disease manifestations in COVID-19 patientsHealth Condition 1: B99-B99- Other infectious diseasesHealth Condition 2: B338- Other specified viral diseasesCTRI/2021/06/034065Dr Swati Datta
Active, not recruiting
Phase 1
Are risk factors factors of pertaining to or involving the heart and blood vessels and markers characterized or caused by inflammation in Rheumatoid Arthritis (a chronic, systemic inflammatory disorder that primarily affects joints) and Systemic Lupus Erythematosus (systemic disease in which the body’s immune system mistakenly attacks healthy tissue)improved? New aspects of Hydroxychloroquine – an interventional study (HCQCVDRASLE)Rheumatoid Arthritis and Systemic Lupus ErythematosusTherapeutic area: Diseases [C] - Immune System Diseases [C20]EUCTR2014-005418-45-SEChristine Bengtsson
Recruiting
Not Applicable
Elucidating the high cardiovascular disease risk in South Asians: focus on monocyte phenotype and incretin hormonesNL-OMON56245Interne Geneeskunde48